Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.
2.

beta(3)-Adrenoceptor agonists: potential, pitfalls and progress.

Arch JR.

Eur J Pharmacol. 2002 Apr 12;440(2-3):99-107. Review.

PMID:
12007528
3.

Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update.

Weyer C, Gautier JF, Danforth E Jr.

Diabetes Metab. 1999 Mar;25(1):11-21. Review.

PMID:
10335419
4.

Substrate competition and insulin action in animal models.

Vettor R, Lombardi AM, Fabris R, Serra R, Pagano C, Macor C, Federspil G.

Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S22-4. Review.

PMID:
10997602
5.

Insulin action in hyperthyroidism: a focus on muscle and adipose tissue.

Mitrou P, Raptis SA, Dimitriadis G.

Endocr Rev. 2010 Oct;31(5):663-79. doi: 10.1210/er.2009-0046. Epub 2010 Jun 2. Review.

PMID:
20519325
6.

Role of Insulin-Stimulated Adipose Tissue Perfusion in the Development of Whole-Body Insulin Resistance.

Emanuel AL, Meijer RI, Muskiet MH, van Raalte DH, Eringa EC, Serné EH.

Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):411-418. doi: 10.1161/ATVBAHA.116.308670. Epub 2017 Jan 26. Review.

7.

Effects of GH in human muscle and fat.

Jørgensen JO, Rubeck KZ, Nielsen TS, Clasen BF, Vendelboe M, Hafstrøm TK, Madsen M, Lund S.

Pediatr Nephrol. 2010 Apr;25(4):705-9. doi: 10.1007/s00467-009-1334-3. Epub 2009 Nov 10. Review.

PMID:
19902270
8.

Neuroendocrine factors regulating blood glucose, plasma FFA and insulin in the development of obesity.

Steffens AB, Strubbe JH, Balkan B, Scheurink AJ.

Brain Res Bull. 1991 Sep-Oct;27(3-4):505-10. Review.

PMID:
1959053
9.

Impact of Alcohol on Glycemic Control and Insulin Action.

Steiner JL, Crowell KT, Lang CH.

Biomolecules. 2015 Sep 29;5(4):2223-46. doi: 10.3390/biom5042223. Review.

Supplemental Content

Support Center